Keyword: biologics

Markets & Companies

New Biologics and Advanced Therapies

13.09.2023 -

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining...

Markets & Companies

Quality and Safety in Biopharmaceutical Production

13.09.2023 -

The biopharmaceutical industry is experiencing a drive towards biologic products due to their promise as treatments for chronic diseases.


Wuxi Biologics Plans Spin-off and Separate Listing of Wuxi XDC

14.07.2023 -

Chinese contract research, development, and manufacturing organization (CRDMO) Wuxi Biologics announced the planned spin-off and separate listing of its subsidiary WuXi...

Markets & Companies

Siegfried Demonstrates Biologics Expertise in Hameln

05.06.2023 -

The Fill & Finish of biologic drugs is expensive and poses special technological challenges for CDMOs. At the German site in Hameln, Siegfried has successfully proven...


Sandoz Builds Biologics Plant in Slovenia

17.03.2023 -

Sandoz, the generics and biosimilars arm of Swiss drugmaker Novartis, has signed a Memorandum of Understanding to build a biologics production plant in Lendava, Slovenia...


Genentech Builds Biologics Facility in California

17.02.2023 -

Genentech, the US biotech arm of Swiss pharma giant Roche, is building a new small-batch biologics manufacturing facility at its Oceanside campus in California, USA...

Markets & Companies

Ramping Up Biomanufacturing Capacity

20.04.2022 -

Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...

Strategy & Management

Managing Supply for Complex Biotherapeutics

16.09.2021 -

Successfully managing the drug substance manufacturing of Antibody-Drug Conjugates (ADCs) requires a sophisticated understanding of the technological development process...